ZHENGYI CHENG: Open Payments
NPI 1316963085 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$821 in 39 payments from 10 companies in 2025. Trend: 2023 $805 · 2024 $1,164 · 2025 $821
Food & beverage: $807Education: $14
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $213 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $153 |
| Gilead Sciences, Inc. | 5 | $106 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $77 |
| Novo Nordisk Inc | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 4 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| PFIZER INC. | 2 | $49 |
| Exact Sciences Corporation | 1 | $25 |
| Lilly USA, LLC | 1 | $15 |
Products named: Kerendia, EVENITY, JARDIANCE, Ozempic, REXULTI, REPATHA, FARXIGA, OTEZLA.
Industry payments across VA — which companies pay providers there.
